Dr. Antonio Hernandez is Senior Clinical Director of Neurodegenerative Disorders at VeraSci. He participates in the development and use of innovative new technologies that assess cognition in Alzheimer’s disease and aging. He also assists in developing and validating new test batteries, reviewing, analyzing and interpreting cognitive test data, and oversees neurocognitive rater certification and data quality control for multi-site pharmaceutical company trials. Other key activities include development of strategic objectives that support the company’s research and development strategies along with establishing strategic partnerships and alliances.
Dr. Hernandez came to VeraSci with over 15 years of clinical research experience across several CNS therapeutic areas. His vast industry experience, exceptional degree of sustained ingenuity, creativity and resourcefulness has been instrumental in shaping the course of many clinical trials in CNS. He has a deep understanding of the clinical as well as operational challenges facing global clinical trials today and has worked closely within multidisciplinary team environments, including business development and marketing. Fluent in Spanish, he has also contributed to the translation and development of eCOA in the assessment of dementia and pre-MCI subjects.
Therapeutic Focus: Alzheimer’s Disease